This is filed to report the patient death.It was reported that on (b)(6) 2018 the mitraclip procedure was intended to be performed in the patient with a fragile state of health and grade 4 degenerative mitral regurgitation (mr).At the start of the procedure, the arterial pressure was approximately 9 to 10 mm hg.During advancement of the steerable guide catheter (sgc), the femoral vein was perforated.There was no resistance felt during advancement of the sgc through the femoral vein, but it is surmised that the physician applied too much force to the sgc during advancement and it went too far and the guide wire was not kept straight during advancement.The procedure was aborted and no mitraclip was implanted due to this adverse event.The arterial pressure dropped down to 3 mm hg.The bleeding was controlled by keeping the sgc in place while the patient was transferred to surgery to repair the femoral lesion.A covered stent was placed and the perforation was sutured.After surgery, the arterial pressure increased to 12 mm hg.The patient expired on (b)(6) 2018 from an unknown cause.There was no issue reported with the device.No additional information was provided.
|
(b)(4).The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot.The reported patient effects of hemorrhage, hypotension, cardiac perforation and death as listed in the mitraclip nt system instructions for use, are known possible complications associated with mitraclip procedures.This event was further reviewed by an abbott vascular medical affairs director.The reviewer concluded that the procedure was conducted in a patient in a fragile condition and led to a complication during advancement of the sgc (steerable guide catheter) resulting in femoral vein complication.Despite surgical repair of the vascular complication; the patient died the following day.It is likely that the bleeding and the surgical procedure further compromised the patients hemodynamic state, ultimately leading to death.This fatal event was procedure-related but not device-related as the procedure was aborted with no clip implanted.It appears that the fragile patient condition together with the procedural complication during advancement of the sgc resulted in the perforation of the femoral vein; the hemorrhage was a result of the perforation; hypotension was related to the combination of the bleeding and the surgical procedure.The mitraclip procedure combined with the cascading patient effects listed above contributed to the patients subsequent death.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|